⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fluoride SCHEMBL28317693 | 1.00 | — | — | |
| SCHEMBL1372796 | 1.00 | — | — | |
| SCHEMBL1374483 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL3992747 | 0.98 | — | — | |
| SCHEMBL31353035 | 0.98 | — | — | |
| Hydrochloric Acid SCHEMBL12469432 | 0.98 | — | — | |
| SCHEMBL546913 | 0.93 | — | — | |
| SCHEMBL4492294 | 0.93 | — | — | |
| SCHEMBL18474377 | 0.93 | — | — | |
| Sulfuric Acid SCHEMBL28773568 | 0.91 | NOS2 (0.52) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 872 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026090333-A1 | COMBINATION USING A KRAS G12D INHIBITOR AND CHEMOTHERAPY COMBINATIONS AS WELL AS THEIR USE IN THE TREATMENT OF CANCER | INCYTE CORPORATION (US) | 2026-04-30 | — | — | WO | claimed |
| US-12503436-B2 | Compounds and compositions for treating conditions associated with STING activity | NOVARTIS PHARMA AG (CH) | 2025-12-23 | — | — | US | claimed |
| EP-4347031-B1 | N-(HYDROXYALKYL (HETERO)ARYL) TETRAHYDROFURAN CARBOXAMIDES AS MODULATORS OF SODIUM CHANNELS | VERTEX PHARMA (US) | 2025-10-29 | — | — | EP | claimed |
| US-12340996-B2 | Method for rapid on-site detection of fentanyl analogs using a miniature mass spectrometer | CHINESE ACADEMY OF INSPECTION AND QUARANTINE (CN) | 2025-06-24 | — | — | US | claimed |
| EP-3816154-B1 | HETEROCYCLIC COMPOUND AND APPLICATION THEREOF | TAKEDA PHARMACEUTICALS CO (JP) | 2025-04-23 | — | — | EP | claimed |
| WO-2025080593-A1 | COMBINATION THERAPY USING A KRAS G12D INHIBITOR AND PD-1 INHIBITOR OR PD-L1 INHIBITOR | INCYTE CORPORATION (US) | 2025-04-17 | — | — | WO | claimed |
| WO-2025080592-A1 | COMBINATION COMPRISING A KRAS G12D INHIBITOR AND AN EGFR INHIBITOR FOR USE IN THE TREATMENT OF CANCER | INCYTE CORPORATION (US) | 2025-04-17 | — | — | WO | claimed |
| EP-4514796-A1 | CDK INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS | OnQuality Pharmaceuticals China Ltd. (CN) | 2025-03-05 | — | — | EP | claimed |
| US-20250051319-A1 | COMPOUNDS AND USE THEREOF AS HDAC6 INHIBITORS | AUGUSTINE THERAPEUTICS (BE) | 2025-02-13 | — | — | US | claimed |
| CN-119285621-A | Tetrahydrofuran carboxamides as sodium channel modulators and their use in medicine | 嘉兴安帝康生物科技有限公司 | 2025-01-10 | — | — | CN | claimed |
| US-6036976-A | BIODEGRADABLE POLYMER FROM EMULSIONS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2000-03-14 | — | — | US | claimed |
| US-5851451-A | Production of microspheres | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1998-12-22 | — | — | US | claimed |
| WO-1998056788-A1 | IMIDAZOLYL-CYCLIC ACETALS | RHONE-POULENC RORER LIMITED (GB) | 1998-12-17 | — | — | WO | claimed |
| WO-1996022786-A1 | SUSTAINED-RELEASE PREPARATION AND USE | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1996-08-01 | — | — | WO | claimed |
| EP-0601799-A1 | Sustained-release preparation | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1994-06-15 | — | — | EP | claimed |
| EP-0311912-B1 | MULTILAYER REVERSE OSMOSIS MEMBRANE IN WHICH ONE LAYER IS POLY-META-PHENYLENE TETRAHYDROFURAN-2,3,4,5-TETRACARBOXAMIDE | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-10-23 | — | — | EP | claimed |
| EP-0167449-B1 | NEW GANGLIOSIDE DERIVATIVES | FIDIA S.p.A. (IT) | 1990-11-28 | — | — | EP | claimed |
| EP-0311912-A1 | Multilayer reverse osmosis membrane in which one layer is poly-meta-phenylene tetrahydrofuran-2,3,4,5-tetracarboxamide | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1989-04-19 | — | — | EP | claimed |
| US-4749488-A | Multilayer reverse osmosis membrane in which one layer is poly-meta-phenylene tetrahydrofuran-2,3,4,5-tetracarboxamide | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1988-06-07 | — | — | US | claimed |
| EP-0167449-A2 | New ganglioside derivatives | FIDIA S.p.A. (IT) | 1986-01-08 | — | — | EP | claimed |